×
-0.0625000000000001 -0.0625000000000001 -0.0625000000000001 -0.0625000000000001 -0.0625000000000001 -0.0625000000000001 -0.0625000000000001 0
Stockreport

Oncotelic Appoints Four Eminent Physician-Scientists Internationally Recognized for their Work in Oncology and Immunology to Newly Established Medical Advisory Board

Mateon Therapeutics (MATN)  More Company Research Source: GlobeNewswire
Last mateon therapeutics earnings: 5/15 09:39 am Check Earnings Report
US:NASDAQ Investor Relations: investor.mateon.com
PDF AGOURA HILLS, Calif., June 12, 2019 (GLOBE NEWSWIRE) -- Oncotelic Inc. (“Oncotelic”), a wholly owned subsidiary of Mateon Therapeutics Inc. (OTCQB: MATN) dedicated to development of innovative treatments for cancer announced today that four internationally recognized clinical scholars have joined its Medical Advisory Board (MAB). Drs. Anatoly Dritschilo, David Horwitz, Reinhard von Roemeling and Stuart Siegel will provide expert advice and strategic guidance to advance the clinical development of the lead anti-cancer drug candidates of Oncotelic.  “I very much look forward to working with my colleagues Drs. Dritschilo, Horwitz, von Roemeling and Siegel as well as collaborating physician-scientists who serve as our consultants to diligently advance our clinical trial program with the vision of bringing  new treatment options to cancer patients who are in urgent need for therapeutic innovations,” said Dr. Fatih Uckun, MD, PhD the Chief Medical Officer of Oncotelic and Mateon wh [Read more]

IMPACT SNAPSHOT EVENT TIME: MATN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
MATN alerts
from News Quantified
Opt-in for
MATN alerts

from News Quantified
Opt-in for
MATN alerts

from News Quantified